{"id":"https://openalex.org/W2112463549","doi":"https://doi.org/10.1158/0008-5472.can-12-3937","title":"Enhanced Inhibition of ERK Signaling by a Novel Allosteric MEK Inhibitor, CH5126766, That Suppresses Feedback Reactivation of RAF Activity","display_name":"Enhanced Inhibition of ERK Signaling by a Novel Allosteric MEK Inhibitor, CH5126766, That Suppresses Feedback Reactivation of RAF Activity","publication_year":2013,"publication_date":"2013-05-11","ids":{"openalex":"https://openalex.org/W2112463549","doi":"https://doi.org/10.1158/0008-5472.can-12-3937","mag":"2112463549","pmid":"https://pubmed.ncbi.nlm.nih.gov/23667175","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4115369"},"language":"en","primary_location":{"id":"doi:10.1158/0008-5472.can-12-3937","doi":"https://doi.org/10.1158/0008-5472.can-12-3937","is_oa":false,"landing_page_url":"https://doi.org/10.1158/0008-5472.can-12-3937","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4115369","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5037187028","display_name":"Nobuya Ishii","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]},{"id":"https://openalex.org/I40677808","display_name":"Kyoto Prefectural University of Medicine","ror":"https://ror.org/028vxwa22","country_code":"JP","type":"education","lineage":["https://openalex.org/I40677808","https://openalex.org/I4405285717"]},{"id":"https://openalex.org/I4405254473","display_name":"Chugai Pharmaceutical Co., Ltd. (Japan)","ror":"https://ror.org/01v743b94","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405254473"]}],"countries":["JP","US"],"is_corresponding":false,"raw_author_name":"Nobuya Ishii","raw_affiliation_strings":["Authors' Affiliations:\u20081Kamakura Research Laboratory, Research Division, Chugai Pharmaceutical Co., Ltd., Kamakura, Japan; 2Program in Molecular Pharmacology and Chemistry, Memorial Sloan-Kettering Cancer Center, New York; and 3Department of Molecular-Targeting Cancer Prevention, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan","Program in Molecular Pharmacology and Chemistry, Memorial Sloan-Kettering Cancer Center, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Kamakura Research Laboratory, Research Division, Chugai Pharmaceutical Co., Ltd., Kamakura, Japan; 2Program in Molecular Pharmacology and Chemistry, Memorial Sloan-Kettering Cancer Center, New York; and 3Department of Molecular-Targeting Cancer Prevention, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan","institution_ids":["https://openalex.org/I1334819555","https://openalex.org/I40677808","https://openalex.org/I4405254473"]},{"raw_affiliation_string":"Program in Molecular Pharmacology and Chemistry, Memorial Sloan-Kettering Cancer Center, New York","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014343297","display_name":"Naoki Harada","orcid":"https://orcid.org/0000-0003-1468-0636","observed_orcids":["https://orcid.org/0000-0003-1468-0636"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]},{"id":"https://openalex.org/I40677808","display_name":"Kyoto Prefectural University of Medicine","ror":"https://ror.org/028vxwa22","country_code":"JP","type":"education","lineage":["https://openalex.org/I40677808","https://openalex.org/I4405285717"]},{"id":"https://openalex.org/I4405254473","display_name":"Chugai Pharmaceutical Co., Ltd. (Japan)","ror":"https://ror.org/01v743b94","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405254473"]}],"countries":["JP","US"],"is_corresponding":false,"raw_author_name":"Naoki Harada","raw_affiliation_strings":["Authors' Affiliations:\u20081Kamakura Research Laboratory, Research Division, Chugai Pharmaceutical Co., Ltd., Kamakura, Japan; 2Program in Molecular Pharmacology and Chemistry, Memorial Sloan-Kettering Cancer Center, New York; and 3Department of Molecular-Targeting Cancer Prevention, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan","Program in Molecular Pharmacology and Chemistry, Memorial Sloan-Kettering Cancer Center, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Kamakura Research Laboratory, Research Division, Chugai Pharmaceutical Co., Ltd., Kamakura, Japan; 2Program in Molecular Pharmacology and Chemistry, Memorial Sloan-Kettering Cancer Center, New York; and 3Department of Molecular-Targeting Cancer Prevention, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan","institution_ids":["https://openalex.org/I1334819555","https://openalex.org/I40677808","https://openalex.org/I4405254473"]},{"raw_affiliation_string":"Program in Molecular Pharmacology and Chemistry, Memorial Sloan-Kettering Cancer Center, New York","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050393601","display_name":"Eric W. Joseph","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]},{"id":"https://openalex.org/I40677808","display_name":"Kyoto Prefectural University of Medicine","ror":"https://ror.org/028vxwa22","country_code":"JP","type":"education","lineage":["https://openalex.org/I40677808","https://openalex.org/I4405285717"]},{"id":"https://openalex.org/I4405254473","display_name":"Chugai Pharmaceutical Co., Ltd. (Japan)","ror":"https://ror.org/01v743b94","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405254473"]}],"countries":["JP","US"],"is_corresponding":false,"raw_author_name":"Eric W. Joseph","raw_affiliation_strings":["Authors' Affiliations:\u20081Kamakura Research Laboratory, Research Division, Chugai Pharmaceutical Co., Ltd., Kamakura, Japan; 2Program in Molecular Pharmacology and Chemistry, Memorial Sloan-Kettering Cancer Center, New York; and 3Department of Molecular-Targeting Cancer Prevention, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan","Program in Molecular Pharmacology and Chemistry, Memorial Sloan-Kettering Cancer Center, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Kamakura Research Laboratory, Research Division, Chugai Pharmaceutical Co., Ltd., Kamakura, Japan; 2Program in Molecular Pharmacology and Chemistry, Memorial Sloan-Kettering Cancer Center, New York; and 3Department of Molecular-Targeting Cancer Prevention, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan","institution_ids":["https://openalex.org/I1334819555","https://openalex.org/I40677808","https://openalex.org/I4405254473"]},{"raw_affiliation_string":"Program in Molecular Pharmacology and Chemistry, Memorial Sloan-Kettering Cancer Center, New York","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102283728","display_name":"Kazuhiro Ohara","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]},{"id":"https://openalex.org/I40677808","display_name":"Kyoto Prefectural University of Medicine","ror":"https://ror.org/028vxwa22","country_code":"JP","type":"education","lineage":["https://openalex.org/I40677808","https://openalex.org/I4405285717"]},{"id":"https://openalex.org/I4405254473","display_name":"Chugai Pharmaceutical Co., Ltd. (Japan)","ror":"https://ror.org/01v743b94","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405254473"]}],"countries":["JP","US"],"is_corresponding":false,"raw_author_name":"Kazuhiro Ohara","raw_affiliation_strings":["Authors' Affiliations:\u20081Kamakura Research Laboratory, Research Division, Chugai Pharmaceutical Co., Ltd., Kamakura, Japan; 2Program in Molecular Pharmacology and Chemistry, Memorial Sloan-Kettering Cancer Center, New York; and 3Department of Molecular-Targeting Cancer Prevention, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan","Program in Molecular Pharmacology and Chemistry, Memorial Sloan-Kettering Cancer Center, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Kamakura Research Laboratory, Research Division, Chugai Pharmaceutical Co., Ltd., Kamakura, Japan; 2Program in Molecular Pharmacology and Chemistry, Memorial Sloan-Kettering Cancer Center, New York; and 3Department of Molecular-Targeting Cancer Prevention, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan","institution_ids":["https://openalex.org/I1334819555","https://openalex.org/I40677808","https://openalex.org/I4405254473"]},{"raw_affiliation_string":"Program in Molecular Pharmacology and Chemistry, Memorial Sloan-Kettering Cancer Center, New York","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071149867","display_name":"Takaaki Miura","orcid":"https://orcid.org/0009-0009-0834-7328","observed_orcids":["https://orcid.org/0009-0009-0834-7328"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]},{"id":"https://openalex.org/I40677808","display_name":"Kyoto Prefectural University of Medicine","ror":"https://ror.org/028vxwa22","country_code":"JP","type":"education","lineage":["https://openalex.org/I40677808","https://openalex.org/I4405285717"]},{"id":"https://openalex.org/I4405254473","display_name":"Chugai Pharmaceutical Co., Ltd. (Japan)","ror":"https://ror.org/01v743b94","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405254473"]}],"countries":["JP","US"],"is_corresponding":false,"raw_author_name":"Takaaki Miura","raw_affiliation_strings":["Authors' Affiliations:\u20081Kamakura Research Laboratory, Research Division, Chugai Pharmaceutical Co., Ltd., Kamakura, Japan; 2Program in Molecular Pharmacology and Chemistry, Memorial Sloan-Kettering Cancer Center, New York; and 3Department of Molecular-Targeting Cancer Prevention, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan","Program in Molecular Pharmacology and Chemistry, Memorial Sloan-Kettering Cancer Center, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Kamakura Research Laboratory, Research Division, Chugai Pharmaceutical Co., Ltd., Kamakura, Japan; 2Program in Molecular Pharmacology and Chemistry, Memorial Sloan-Kettering Cancer Center, New York; and 3Department of Molecular-Targeting Cancer Prevention, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan","institution_ids":["https://openalex.org/I1334819555","https://openalex.org/I40677808","https://openalex.org/I4405254473"]},{"raw_affiliation_string":"Program in Molecular Pharmacology and Chemistry, Memorial Sloan-Kettering Cancer Center, New York","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Hiroshi Sakamoto","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]},{"id":"https://openalex.org/I40677808","display_name":"Kyoto Prefectural University of Medicine","ror":"https://ror.org/028vxwa22","country_code":"JP","type":"education","lineage":["https://openalex.org/I40677808","https://openalex.org/I4405285717"]},{"id":"https://openalex.org/I4405254473","display_name":"Chugai Pharmaceutical Co., Ltd. (Japan)","ror":"https://ror.org/01v743b94","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405254473"]}],"countries":["JP","US"],"is_corresponding":false,"raw_author_name":"Hiroshi Sakamoto","raw_affiliation_strings":["Authors' Affiliations:\u20081Kamakura Research Laboratory, Research Division, Chugai Pharmaceutical Co., Ltd., Kamakura, Japan; 2Program in Molecular Pharmacology and Chemistry, Memorial Sloan-Kettering Cancer Center, New York; and 3Department of Molecular-Targeting Cancer Prevention, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan","Program in Molecular Pharmacology and Chemistry, Memorial Sloan-Kettering Cancer Center, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Kamakura Research Laboratory, Research Division, Chugai Pharmaceutical Co., Ltd., Kamakura, Japan; 2Program in Molecular Pharmacology and Chemistry, Memorial Sloan-Kettering Cancer Center, New York; and 3Department of Molecular-Targeting Cancer Prevention, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan","institution_ids":["https://openalex.org/I1334819555","https://openalex.org/I40677808","https://openalex.org/I4405254473"]},{"raw_affiliation_string":"Program in Molecular Pharmacology and Chemistry, Memorial Sloan-Kettering Cancer Center, New York","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025535885","display_name":"Yutaka Matsuda","orcid":"https://orcid.org/0000-0003-2801-4706","observed_orcids":["https://orcid.org/0000-0003-2801-4706"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]},{"id":"https://openalex.org/I40677808","display_name":"Kyoto Prefectural University of Medicine","ror":"https://ror.org/028vxwa22","country_code":"JP","type":"education","lineage":["https://openalex.org/I40677808","https://openalex.org/I4405285717"]},{"id":"https://openalex.org/I4405254473","display_name":"Chugai Pharmaceutical Co., Ltd. (Japan)","ror":"https://ror.org/01v743b94","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405254473"]}],"countries":["JP","US"],"is_corresponding":false,"raw_author_name":"Yutaka Matsuda","raw_affiliation_strings":["Authors' Affiliations:\u20081Kamakura Research Laboratory, Research Division, Chugai Pharmaceutical Co., Ltd., Kamakura, Japan; 2Program in Molecular Pharmacology and Chemistry, Memorial Sloan-Kettering Cancer Center, New York; and 3Department of Molecular-Targeting Cancer Prevention, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan","Program in Molecular Pharmacology and Chemistry, Memorial Sloan-Kettering Cancer Center, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Kamakura Research Laboratory, Research Division, Chugai Pharmaceutical Co., Ltd., Kamakura, Japan; 2Program in Molecular Pharmacology and Chemistry, Memorial Sloan-Kettering Cancer Center, New York; and 3Department of Molecular-Targeting Cancer Prevention, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan","institution_ids":["https://openalex.org/I1334819555","https://openalex.org/I40677808","https://openalex.org/I4405254473"]},{"raw_affiliation_string":"Program in Molecular Pharmacology and Chemistry, Memorial Sloan-Kettering Cancer Center, New York","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5114045540","display_name":"Yasushi Tomii","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]},{"id":"https://openalex.org/I40677808","display_name":"Kyoto Prefectural University of Medicine","ror":"https://ror.org/028vxwa22","country_code":"JP","type":"education","lineage":["https://openalex.org/I40677808","https://openalex.org/I4405285717"]},{"id":"https://openalex.org/I4405254473","display_name":"Chugai Pharmaceutical Co., Ltd. (Japan)","ror":"https://ror.org/01v743b94","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405254473"]}],"countries":["JP","US"],"is_corresponding":false,"raw_author_name":"Yasushi Tomii","raw_affiliation_strings":["Authors' Affiliations:\u20081Kamakura Research Laboratory, Research Division, Chugai Pharmaceutical Co., Ltd., Kamakura, Japan; 2Program in Molecular Pharmacology and Chemistry, Memorial Sloan-Kettering Cancer Center, New York; and 3Department of Molecular-Targeting Cancer Prevention, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan","Program in Molecular Pharmacology and Chemistry, Memorial Sloan-Kettering Cancer Center, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Kamakura Research Laboratory, Research Division, Chugai Pharmaceutical Co., Ltd., Kamakura, Japan; 2Program in Molecular Pharmacology and Chemistry, Memorial Sloan-Kettering Cancer Center, New York; and 3Department of Molecular-Targeting Cancer Prevention, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan","institution_ids":["https://openalex.org/I1334819555","https://openalex.org/I40677808","https://openalex.org/I4405254473"]},{"raw_affiliation_string":"Program in Molecular Pharmacology and Chemistry, Memorial Sloan-Kettering Cancer Center, New York","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012782189","display_name":"Yukako Tachibana-Kondo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]},{"id":"https://openalex.org/I40677808","display_name":"Kyoto Prefectural University of Medicine","ror":"https://ror.org/028vxwa22","country_code":"JP","type":"education","lineage":["https://openalex.org/I40677808","https://openalex.org/I4405285717"]},{"id":"https://openalex.org/I4405254473","display_name":"Chugai Pharmaceutical Co., Ltd. (Japan)","ror":"https://ror.org/01v743b94","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405254473"]}],"countries":["JP","US"],"is_corresponding":false,"raw_author_name":"Yukako Tachibana-Kondo","raw_affiliation_strings":["Authors' Affiliations:\u20081Kamakura Research Laboratory, Research Division, Chugai Pharmaceutical Co., Ltd., Kamakura, Japan; 2Program in Molecular Pharmacology and Chemistry, Memorial Sloan-Kettering Cancer Center, New York; and 3Department of Molecular-Targeting Cancer Prevention, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan","Program in Molecular Pharmacology and Chemistry, Memorial Sloan-Kettering Cancer Center, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Kamakura Research Laboratory, Research Division, Chugai Pharmaceutical Co., Ltd., Kamakura, Japan; 2Program in Molecular Pharmacology and Chemistry, Memorial Sloan-Kettering Cancer Center, New York; and 3Department of Molecular-Targeting Cancer Prevention, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan","institution_ids":["https://openalex.org/I1334819555","https://openalex.org/I40677808","https://openalex.org/I4405254473"]},{"raw_affiliation_string":"Program in Molecular Pharmacology and Chemistry, Memorial Sloan-Kettering Cancer Center, New York","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110935593","display_name":"Hitoshi Iikura","orcid":"https://orcid.org/0009-0007-0392-8663","observed_orcids":["https://orcid.org/0009-0007-0392-8663"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]},{"id":"https://openalex.org/I40677808","display_name":"Kyoto Prefectural University of Medicine","ror":"https://ror.org/028vxwa22","country_code":"JP","type":"education","lineage":["https://openalex.org/I40677808","https://openalex.org/I4405285717"]},{"id":"https://openalex.org/I4405254473","display_name":"Chugai Pharmaceutical Co., Ltd. (Japan)","ror":"https://ror.org/01v743b94","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405254473"]}],"countries":["JP","US"],"is_corresponding":false,"raw_author_name":"Hitoshi Iikura","raw_affiliation_strings":["Authors' Affiliations:\u20081Kamakura Research Laboratory, Research Division, Chugai Pharmaceutical Co., Ltd., Kamakura, Japan; 2Program in Molecular Pharmacology and Chemistry, Memorial Sloan-Kettering Cancer Center, New York; and 3Department of Molecular-Targeting Cancer Prevention, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan","Program in Molecular Pharmacology and Chemistry, Memorial Sloan-Kettering Cancer Center, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Kamakura Research Laboratory, Research Division, Chugai Pharmaceutical Co., Ltd., Kamakura, Japan; 2Program in Molecular Pharmacology and Chemistry, Memorial Sloan-Kettering Cancer Center, New York; and 3Department of Molecular-Targeting Cancer Prevention, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan","institution_ids":["https://openalex.org/I1334819555","https://openalex.org/I40677808","https://openalex.org/I4405254473"]},{"raw_affiliation_string":"Program in Molecular Pharmacology and Chemistry, Memorial Sloan-Kettering Cancer Center, New York","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Toshihiro Aoki","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]},{"id":"https://openalex.org/I40677808","display_name":"Kyoto Prefectural University of Medicine","ror":"https://ror.org/028vxwa22","country_code":"JP","type":"education","lineage":["https://openalex.org/I40677808","https://openalex.org/I4405285717"]},{"id":"https://openalex.org/I4405254473","display_name":"Chugai Pharmaceutical Co., Ltd. (Japan)","ror":"https://ror.org/01v743b94","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405254473"]}],"countries":["JP","US"],"is_corresponding":false,"raw_author_name":"Toshihiro Aoki","raw_affiliation_strings":["Authors' Affiliations:\u20081Kamakura Research Laboratory, Research Division, Chugai Pharmaceutical Co., Ltd., Kamakura, Japan; 2Program in Molecular Pharmacology and Chemistry, Memorial Sloan-Kettering Cancer Center, New York; and 3Department of Molecular-Targeting Cancer Prevention, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan","Program in Molecular Pharmacology and Chemistry, Memorial Sloan-Kettering Cancer Center, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Kamakura Research Laboratory, Research Division, Chugai Pharmaceutical Co., Ltd., Kamakura, Japan; 2Program in Molecular Pharmacology and Chemistry, Memorial Sloan-Kettering Cancer Center, New York; and 3Department of Molecular-Targeting Cancer Prevention, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan","institution_ids":["https://openalex.org/I1334819555","https://openalex.org/I40677808","https://openalex.org/I4405254473"]},{"raw_affiliation_string":"Program in Molecular Pharmacology and Chemistry, Memorial Sloan-Kettering Cancer Center, New York","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044372755","display_name":"Nobuo Shimma","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]},{"id":"https://openalex.org/I40677808","display_name":"Kyoto Prefectural University of Medicine","ror":"https://ror.org/028vxwa22","country_code":"JP","type":"education","lineage":["https://openalex.org/I40677808","https://openalex.org/I4405285717"]},{"id":"https://openalex.org/I4405254473","display_name":"Chugai Pharmaceutical Co., Ltd. (Japan)","ror":"https://ror.org/01v743b94","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405254473"]}],"countries":["JP","US"],"is_corresponding":false,"raw_author_name":"Nobuo Shimma","raw_affiliation_strings":["Authors' Affiliations:\u20081Kamakura Research Laboratory, Research Division, Chugai Pharmaceutical Co., Ltd., Kamakura, Japan; 2Program in Molecular Pharmacology and Chemistry, Memorial Sloan-Kettering Cancer Center, New York; and 3Department of Molecular-Targeting Cancer Prevention, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan","Program in Molecular Pharmacology and Chemistry, Memorial Sloan-Kettering Cancer Center, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Kamakura Research Laboratory, Research Division, Chugai Pharmaceutical Co., Ltd., Kamakura, Japan; 2Program in Molecular Pharmacology and Chemistry, Memorial Sloan-Kettering Cancer Center, New York; and 3Department of Molecular-Targeting Cancer Prevention, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan","institution_ids":["https://openalex.org/I1334819555","https://openalex.org/I40677808","https://openalex.org/I4405254473"]},{"raw_affiliation_string":"Program in Molecular Pharmacology and Chemistry, Memorial Sloan-Kettering Cancer Center, New York","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007571413","display_name":"Mikio Arisawa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]},{"id":"https://openalex.org/I40677808","display_name":"Kyoto Prefectural University of Medicine","ror":"https://ror.org/028vxwa22","country_code":"JP","type":"education","lineage":["https://openalex.org/I40677808","https://openalex.org/I4405285717"]},{"id":"https://openalex.org/I4405254473","display_name":"Chugai Pharmaceutical Co., Ltd. (Japan)","ror":"https://ror.org/01v743b94","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405254473"]}],"countries":["JP","US"],"is_corresponding":false,"raw_author_name":"Mikio Arisawa","raw_affiliation_strings":["Authors' Affiliations:\u20081Kamakura Research Laboratory, Research Division, Chugai Pharmaceutical Co., Ltd., Kamakura, Japan; 2Program in Molecular Pharmacology and Chemistry, Memorial Sloan-Kettering Cancer Center, New York; and 3Department of Molecular-Targeting Cancer Prevention, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan","Program in Molecular Pharmacology and Chemistry, Memorial Sloan-Kettering Cancer Center, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Kamakura Research Laboratory, Research Division, Chugai Pharmaceutical Co., Ltd., Kamakura, Japan; 2Program in Molecular Pharmacology and Chemistry, Memorial Sloan-Kettering Cancer Center, New York; and 3Department of Molecular-Targeting Cancer Prevention, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan","institution_ids":["https://openalex.org/I1334819555","https://openalex.org/I40677808","https://openalex.org/I4405254473"]},{"raw_affiliation_string":"Program in Molecular Pharmacology and Chemistry, Memorial Sloan-Kettering Cancer Center, New York","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020827484","display_name":"Yoshihiro Sowa","orcid":"https://orcid.org/0000-0001-5531-9009","observed_orcids":["https://orcid.org/0000-0001-5531-9009"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]},{"id":"https://openalex.org/I40677808","display_name":"Kyoto Prefectural University of Medicine","ror":"https://ror.org/028vxwa22","country_code":"JP","type":"education","lineage":["https://openalex.org/I40677808","https://openalex.org/I4405285717"]},{"id":"https://openalex.org/I4405254473","display_name":"Chugai Pharmaceutical Co., Ltd. (Japan)","ror":"https://ror.org/01v743b94","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405254473"]}],"countries":["JP","US"],"is_corresponding":false,"raw_author_name":"Yoshihiro Sowa","raw_affiliation_strings":["Authors' Affiliations:\u20081Kamakura Research Laboratory, Research Division, Chugai Pharmaceutical Co., Ltd., Kamakura, Japan; 2Program in Molecular Pharmacology and Chemistry, Memorial Sloan-Kettering Cancer Center, New York; and 3Department of Molecular-Targeting Cancer Prevention, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan","Program in Molecular Pharmacology and Chemistry, Memorial Sloan-Kettering Cancer Center, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Kamakura Research Laboratory, Research Division, Chugai Pharmaceutical Co., Ltd., Kamakura, Japan; 2Program in Molecular Pharmacology and Chemistry, Memorial Sloan-Kettering Cancer Center, New York; and 3Department of Molecular-Targeting Cancer Prevention, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan","institution_ids":["https://openalex.org/I1334819555","https://openalex.org/I40677808","https://openalex.org/I4405254473"]},{"raw_affiliation_string":"Program in Molecular Pharmacology and Chemistry, Memorial Sloan-Kettering Cancer Center, New York","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078118619","display_name":"Poulikos I. Poulikakos","orcid":"https://orcid.org/0000-0001-6071-9963","observed_orcids":["https://orcid.org/0000-0001-6071-9963"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]},{"id":"https://openalex.org/I40677808","display_name":"Kyoto Prefectural University of Medicine","ror":"https://ror.org/028vxwa22","country_code":"JP","type":"education","lineage":["https://openalex.org/I40677808","https://openalex.org/I4405285717"]},{"id":"https://openalex.org/I4405254473","display_name":"Chugai Pharmaceutical Co., Ltd. (Japan)","ror":"https://ror.org/01v743b94","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405254473"]}],"countries":["JP","US"],"is_corresponding":false,"raw_author_name":"Poulikos I. Poulikakos","raw_affiliation_strings":["Authors' Affiliations:\u20081Kamakura Research Laboratory, Research Division, Chugai Pharmaceutical Co., Ltd., Kamakura, Japan; 2Program in Molecular Pharmacology and Chemistry, Memorial Sloan-Kettering Cancer Center, New York; and 3Department of Molecular-Targeting Cancer Prevention, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan","Program in Molecular Pharmacology and Chemistry, Memorial Sloan-Kettering Cancer Center, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Kamakura Research Laboratory, Research Division, Chugai Pharmaceutical Co., Ltd., Kamakura, Japan; 2Program in Molecular Pharmacology and Chemistry, Memorial Sloan-Kettering Cancer Center, New York; and 3Department of Molecular-Targeting Cancer Prevention, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan","institution_ids":["https://openalex.org/I1334819555","https://openalex.org/I40677808","https://openalex.org/I4405254473"]},{"raw_affiliation_string":"Program in Molecular Pharmacology and Chemistry, Memorial Sloan-Kettering Cancer Center, New York","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060228803","display_name":"Neal X. Rosen","orcid":"https://orcid.org/0000-0002-8307-654X","observed_orcids":["https://orcid.org/0000-0002-8307-654X"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]},{"id":"https://openalex.org/I40677808","display_name":"Kyoto Prefectural University of Medicine","ror":"https://ror.org/028vxwa22","country_code":"JP","type":"education","lineage":["https://openalex.org/I40677808","https://openalex.org/I4405285717"]},{"id":"https://openalex.org/I4405254473","display_name":"Chugai Pharmaceutical Co., Ltd. (Japan)","ror":"https://ror.org/01v743b94","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405254473"]}],"countries":["JP","US"],"is_corresponding":true,"raw_author_name":"Neal Rosen","raw_affiliation_strings":["Authors' Affiliations:\u20081Kamakura Research Laboratory, Research Division, Chugai Pharmaceutical Co., Ltd., Kamakura, Japan; 2Program in Molecular Pharmacology and Chemistry, Memorial Sloan-Kettering Cancer Center, New York; and 3Department of Molecular-Targeting Cancer Prevention, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan","Program in Molecular Pharmacology and Chemistry, Memorial Sloan-Kettering Cancer Center, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Kamakura Research Laboratory, Research Division, Chugai Pharmaceutical Co., Ltd., Kamakura, Japan; 2Program in Molecular Pharmacology and Chemistry, Memorial Sloan-Kettering Cancer Center, New York; and 3Department of Molecular-Targeting Cancer Prevention, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan","institution_ids":["https://openalex.org/I1334819555","https://openalex.org/I40677808","https://openalex.org/I4405254473"]},{"raw_affiliation_string":"Program in Molecular Pharmacology and Chemistry, Memorial Sloan-Kettering Cancer Center, New York","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108748469","display_name":"Yuko Aoki","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]},{"id":"https://openalex.org/I40677808","display_name":"Kyoto Prefectural University of Medicine","ror":"https://ror.org/028vxwa22","country_code":"JP","type":"education","lineage":["https://openalex.org/I40677808","https://openalex.org/I4405285717"]},{"id":"https://openalex.org/I4405254473","display_name":"Chugai Pharmaceutical Co., Ltd. (Japan)","ror":"https://ror.org/01v743b94","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405254473"]}],"countries":["JP","US"],"is_corresponding":true,"raw_author_name":"Yuko Aoki","raw_affiliation_strings":["Authors' Affiliations:\u20081Kamakura Research Laboratory, Research Division, Chugai Pharmaceutical Co., Ltd., Kamakura, Japan; 2Program in Molecular Pharmacology and Chemistry, Memorial Sloan-Kettering Cancer Center, New York; and 3Department of Molecular-Targeting Cancer Prevention, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan","Program in Molecular Pharmacology and Chemistry, Memorial Sloan-Kettering Cancer Center, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Kamakura Research Laboratory, Research Division, Chugai Pharmaceutical Co., Ltd., Kamakura, Japan; 2Program in Molecular Pharmacology and Chemistry, Memorial Sloan-Kettering Cancer Center, New York; and 3Department of Molecular-Targeting Cancer Prevention, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan","institution_ids":["https://openalex.org/I1334819555","https://openalex.org/I40677808","https://openalex.org/I4405254473"]},{"raw_affiliation_string":"Program in Molecular Pharmacology and Chemistry, Memorial Sloan-Kettering Cancer Center, New York","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5013263645","display_name":"Toshiyuki Sakai","orcid":"https://orcid.org/0000-0002-7865-2258","observed_orcids":["https://orcid.org/0000-0002-7865-2258"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]},{"id":"https://openalex.org/I40677808","display_name":"Kyoto Prefectural University of Medicine","ror":"https://ror.org/028vxwa22","country_code":"JP","type":"education","lineage":["https://openalex.org/I40677808","https://openalex.org/I4405285717"]},{"id":"https://openalex.org/I4405254473","display_name":"Chugai Pharmaceutical Co., Ltd. (Japan)","ror":"https://ror.org/01v743b94","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405254473"]}],"countries":["JP","US"],"is_corresponding":true,"raw_author_name":"Toshiyuki Sakai","raw_affiliation_strings":["Authors' Affiliations:\u20081Kamakura Research Laboratory, Research Division, Chugai Pharmaceutical Co., Ltd., Kamakura, Japan; 2Program in Molecular Pharmacology and Chemistry, Memorial Sloan-Kettering Cancer Center, New York; and 3Department of Molecular-Targeting Cancer Prevention, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan","Program in Molecular Pharmacology and Chemistry, Memorial Sloan-Kettering Cancer Center, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Kamakura Research Laboratory, Research Division, Chugai Pharmaceutical Co., Ltd., Kamakura, Japan; 2Program in Molecular Pharmacology and Chemistry, Memorial Sloan-Kettering Cancer Center, New York; and 3Department of Molecular-Targeting Cancer Prevention, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan","institution_ids":["https://openalex.org/I1334819555","https://openalex.org/I40677808","https://openalex.org/I4405254473"]},{"raw_affiliation_string":"Program in Molecular Pharmacology and Chemistry, Memorial Sloan-Kettering Cancer Center, New York","institution_ids":["https://openalex.org/I1334819555"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5013263645","https://openalex.org/A5060228803","https://openalex.org/A5108748469"],"corresponding_institution_ids":["https://openalex.org/I1334819555","https://openalex.org/I40677808","https://openalex.org/I4405254473"],"apc_list":null,"apc_paid":null,"fwci":5.3435,"has_fulltext":false,"cited_by_count":182,"citation_normalized_percentile":{"value":0.97404824,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":97,"max":100},"biblio":{"volume":"73","issue":"13","first_page":"4050","last_page":"4060"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10169","display_name":"Protein Kinase Regulation and GTPase Signaling","score":0.003800000064074993,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12104","display_name":"Protein Tyrosine Phosphatases","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/mek-inhibitors","display_name":"MEK inhibitors","score":0.7789999842643738},{"id":"https://openalex.org/keywords/allosteric-inhibition","display_name":"allosteric inhibition","score":0.9010000228881836},{"id":"https://openalex.org/keywords/raf-kinase","display_name":"Raf kinase","score":0.7020000219345093},{"id":"https://openalex.org/keywords/erk-signaling","display_name":"ERK signaling","score":0.8899999856948853},{"id":"https://openalex.org/keywords/ras-mutations","display_name":"RAS mutations","score":0.6809999942779541},{"id":"https://openalex.org/keywords/mek-phosphorylation","display_name":"MEK phosphorylation","score":0.8740000128746033},{"id":"https://openalex.org/keywords/dominant-negative-inhibition","display_name":"dominant negative inhibition","score":0.796999990940094},{"id":"https://openalex.org/keywords/anticancer-activity","display_name":"anticancer activity","score":0.7829999923706055}],"concepts":[{"id":"https://openalex.org/C57074206","wikidata":"https://www.wikidata.org/wiki/Q14197552","display_name":"MAPK/ERK pathway","level":3,"score":0.850004255771637},{"id":"https://openalex.org/C2781249067","wikidata":"https://www.wikidata.org/wiki/Q17142288","display_name":"MEK inhibitor","level":4,"score":0.8367781639099121},{"id":"https://openalex.org/C11960822","wikidata":"https://www.wikidata.org/wiki/Q242736","display_name":"Phosphorylation","level":2,"score":0.667993426322937},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.6110685467720032},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.49814295768737793},{"id":"https://openalex.org/C166342909","wikidata":"https://www.wikidata.org/wiki/Q845326","display_name":"Allosteric regulation","level":3,"score":0.48017898201942444},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.42487776279449463},{"id":"https://openalex.org/C97029542","wikidata":"https://www.wikidata.org/wiki/Q281417","display_name":"Protein kinase A","level":3,"score":0.41721421480178833},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.40010690689086914},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.37182068824768066},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2634000778198242},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.1838890016078949},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.12102892994880676}],"mesh":[{"descriptor_ui":"D000494","descriptor_name":"Allosteric Regulation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D003374","descriptor_name":"Coumarins","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D004789","descriptor_name":"Enzyme Activation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008807","descriptor_name":"Mice, Inbred BALB C","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008819","descriptor_name":"Mice, Nude","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010766","descriptor_name":"Phosphorylation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011485","descriptor_name":"Protein Binding","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011499","descriptor_name":"Protein Processing, Post-Translational","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011518","descriptor_name":"Proto-Oncogene Proteins","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D016283","descriptor_name":"Proto-Oncogene Proteins p21(ras)","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018631","descriptor_name":"ras Proteins","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D019908","descriptor_name":"Proto-Oncogene Proteins c-raf","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D019908","descriptor_name":"Proto-Oncogene Proteins c-raf","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D020935","descriptor_name":"MAP Kinase Signaling System","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D023041","descriptor_name":"Xenograft Model Antitumor Assays","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D025461","descriptor_name":"Feedback, Physiological","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D048049","descriptor_name":"Extracellular Signal-Regulated MAP Kinases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D048369","descriptor_name":"MAP Kinase Kinase 1","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D048369","descriptor_name":"MAP Kinase Kinase 1","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D048369","descriptor_name":"MAP Kinase Kinase 1","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D048493","descriptor_name":"Proto-Oncogene Proteins B-raf","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D048493","descriptor_name":"Proto-Oncogene Proteins B-raf","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1158/0008-5472.can-12-3937","doi":"https://doi.org/10.1158/0008-5472.can-12-3937","is_oa":false,"landing_page_url":"https://doi.org/10.1158/0008-5472.can-12-3937","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},{"id":"pmid:23667175","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23667175","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer research","raw_type":"Journal Article"},{"id":"pmh:oai:europepmc.org:3082533","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4115369","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:4115369","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4115369/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Cancer Res","raw_type":"Text"}],"best_oa_location":{"id":"pmh:oai:europepmc.org:3082533","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4115369","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"Text"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.8560000061988831,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G3690077713","display_name":"Targets for Therapy for Carcinomas of the Lung","funder_award_id":"P01CA129243","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G7335454695","display_name":"Cancer Pharmacology","funder_award_id":"T32CA062948","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320306155","display_name":"Cancer Research Institute","ror":"https://ror.org/02f3xk561"},{"id":"https://openalex.org/F4320333003","display_name":"Chugai Pharmaceutical","ror":"https://ror.org/01vepzj85"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":34,"referenced_works":["https://openalex.org/W1507247257","https://openalex.org/W1971947883","https://openalex.org/W1981976406","https://openalex.org/W1982972087","https://openalex.org/W1988729646","https://openalex.org/W1991845461","https://openalex.org/W2002468669","https://openalex.org/W2004295816","https://openalex.org/W2011033752","https://openalex.org/W2020292268","https://openalex.org/W2035936653","https://openalex.org/W2038683568","https://openalex.org/W2041098455","https://openalex.org/W2050206485","https://openalex.org/W2050422354","https://openalex.org/W2051165598","https://openalex.org/W2054292493","https://openalex.org/W2057629729","https://openalex.org/W2068652881","https://openalex.org/W2074867181","https://openalex.org/W2098426299","https://openalex.org/W2100738068","https://openalex.org/W2116357670","https://openalex.org/W2118549562","https://openalex.org/W2128542677","https://openalex.org/W2136474966","https://openalex.org/W2136745780","https://openalex.org/W2138516325","https://openalex.org/W2144708319","https://openalex.org/W2149662085","https://openalex.org/W2158213613","https://openalex.org/W2264782638","https://openalex.org/W2767686444","https://openalex.org/W6647675393"],"related_works":["https://openalex.org/W2005117937","https://openalex.org/W2330060177","https://openalex.org/W2761912328","https://openalex.org/W2793987275","https://openalex.org/W2789608969","https://openalex.org/W2060440543","https://openalex.org/W2740261576","https://openalex.org/W2560903486","https://openalex.org/W2001567188","https://openalex.org/W4367603723"],"abstract_inverted_index":{"Tumors":[0],"with":[1,94,173],"mutant":[2,174],"RAS":[3],"are":[4],"often":[5],"dependent":[6],"on":[7],"extracellular":[8],"signal-regulated":[9],"kinase":[10,57],"(ERK)":[11],"signaling":[12,107],"for":[13],"growth;":[14],"however,":[15],"MEK":[16,26,38,45,63,102,114,118,140,148,152],"inhibitors":[17,27],"have":[18,41,166],"only":[19],"marginal":[20],"antitumor":[21,123],"activity":[22,124,169],"in":[23,68,81,162,170],"these":[24],"tumors.":[25],"relieve":[28],"ERK-dependent":[29,171],"feedback":[30,134],"inhibition":[31,89,137],"of":[32,37,54,83,90,132,147,158],"RAF":[33,56,91,133,159],"and":[34,75,88,120,160],"cause":[35],"induction":[36],"phosphorylation.":[39,103],"We":[40],"now":[42],"identified":[43],"a":[44,66,84,112,144,155],"inhibitor,":[46],"CH5126766":[47,60,104,142],"(RO5126766),":[48],"that":[49,116,130,150],"has":[50,121],"the":[51],"unique":[52],"property":[53],"inhibiting":[55],"as":[58,125],"well.":[59,126],"binding":[61],"causes":[62,151],"to":[64,153],"adopt":[65],"conformation":[67],"which":[69],"it":[70],"cannot":[71],"be":[72],"phosphorylated":[73],"by":[74,138],"released":[76],"from":[77],"RAF.":[78],"This":[79],"results":[80,128],"formation":[82],"stable":[85],"MEK/RAF":[86],"complex":[87],"kinase.":[92],"Consistent":[93],"this":[95,97],"mechanism,":[96],"drug":[98],"does":[99],"not":[100],"induce":[101],"inhibits":[105],"ERK":[106],"output":[108],"more":[109],"effectively":[110],"than":[111],"standard":[113,139],"inhibitor":[115,149,157],"induces":[117],"phosphorylation":[119],"potent":[122],"These":[127],"suggest":[129],"relief":[131],"limits":[135],"pathway":[136],"inhibitors.":[141],"represents":[143],"new":[145],"type":[146],"become":[154],"dominant-negative":[156],"that,":[161],"doing":[163],"so,":[164],"may":[165],"enhanced":[167],"therapeutic":[168],"tumors":[172],"RAS.":[175]},"counts_by_year":[{"year":2026,"cited_by_count":23},{"year":2025,"cited_by_count":16},{"year":2024,"cited_by_count":15},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":8},{"year":2021,"cited_by_count":20},{"year":2020,"cited_by_count":9},{"year":2019,"cited_by_count":17},{"year":2018,"cited_by_count":12},{"year":2017,"cited_by_count":7},{"year":2016,"cited_by_count":7},{"year":2015,"cited_by_count":18},{"year":2014,"cited_by_count":19},{"year":2013,"cited_by_count":5}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2016-06-24T00:00:00"}